Potassium
Hypokalemia
search
Hypokalemia
, Hypokalemia Related EKG Changes
See Also
Serum Potassium
Hypokalemia due to Renal Potassium Loss
Hypokalemia due to Extrarenal Potassium Loss
Hypokalemia due to Transcellular Potassium Shift
Drug-Induced Hypokalemia
Familial Periodic Paralysis
Potassium Replacement
Dietary Potassium
Prevention of Diuretic-Induced Hypokalemia
Epidemiology
Prevalence
Gene
ral Population: 1.9%
Emergency Department: 5.5%
Inpatient: 2.9 to 7.4%
Brookes (2021) Intern Med J 51(11): 1906-18 [PubMed]
Kovesdy (2018) Eur Heart J 39(17): 1535-42 [PubMed]
Singer (2017) Clin Exp Emerg Med 4(2): 73-9 [PubMed]
Pathophysiology
See
Potassium Homeostasis
Approximate Total body
Potassium
= 55 meq/kg
Serum Potassium
decreased 0.3 mEq/L: 100 mEq K+ total body deficit
Serum Potassium
decreased 1 mEq/L: 350 mEq K+ total body deficit
Serum Potassium
less than 2 mEq/L: 1000 mEq K+ total body deficit
Images
Causes
Hypokalemia due to Transcellular Potassium Shift
See
Transcellular Potassium Shift
Medications (Beta-
Agonist
s,
Insulin
excess,
Caffeine
,
Theophylline
)
Metabolic Alkalosis
Hypokalemic Periodic Paralysis
Thyrotoxicosis
Hypothermia
Refeeding Syndrome
Hypokalemia due to Renal Potassium Loss
See
Renal Potassium Loss
(
Hyperkaluria
)
Hypertension
: Obtain Plasma
Renin
and
Aldosterone
Renin
high
Renovascular disease
Renin
Secretin
g tumor
Malignant Hypertension
Renin
normal
Liddle Syndrome
Renin
low
Aldosterone
High
Primary Hyperaldosteronism
Bilateral adrenal hyperplasia
Aldosterone
Low
Congenital Adrenal Hyperplasia
Cushing's Syndrome
Ectopic
ACTH
Exogenous
Corticosteroid
s (e.g.
Prednisone
)
Normotensive: Obtain
Serum Magnesium
, serum bicarbonate and
Urine Chloride
Hypomagnesemia
See
Hypomagnesemia Causes
Serum Bicarbonate Low
Renal Tubular Acidosis
(Types 1 and 2)
Serum Bicarbonate High
Urine Chloride
Low:
Vomiting
Urine Chloride
High
Intrinsic renal transport defect (Bartter Syndrome, Gitelman Syndrome)
Normotensive
Primary Hyperaldosteronism
Diuretic
use (
Loop Diuretic
s,
Thiazide Diuretic
s)
Hypokalemia due to Extrarenal Potassium Loss
See
Extrarenal Potassium Loss
Normal Acid-Base Status or
Metabolic Alkalosis
Gastrointestinal or skin losses
Hypomagnesemia
Medications (e.g.
Penicillin
or
Aminoglycoside
s,
Sodium Polystyrene Sulfonate
)
Acute Leukemia
Metabolic Acidosis
Diabetic Ketoacidosis
Diarrhea
Laxative
s
Other causes
See
Drug-Induced Hypokalemia
Inadequate
Potassium
intake (typically in hospitalized patients)
Total Parenteral Nutrition
Anorexia
or Starvation
Dementia
Pseudohypokalemia
Delayed lab analysis of sample
Severe
Leukocytosis
(>75,000 to 100,000/mm3)
Recent
Insulin
administration
Findings
Symptoms and Signs (when
Serum Potassium
< 2.5 mEq/L or with rapid drop in
Serum Potassium
)
Gene
ral
Malaise
Fatigue
Neurologic
Weakness
Decreased
Deep Tendon Reflex
es
Paresthesia
Cramps
Restless Legs Syndrome
Rhabdomyolysis
Paralysis
Gastrointestinal
Constipation
Ileus
Exacerbated
Hepatic Encephalopathy
in
Cirrhosis
Kidney
retains
Potassium
in exchange for
Hydrogen Ion
, resulting in increased ammonia synthesis
Cardiovascular
Orthostatic Hypotension
Hypertension
Arrhythmia
s (rare in otherwise healthy patients)
Acute or recent
Myocardial Infarction
(5 fold increased risk of
Ventricular Fibrillation
if K+ <3.9 mEq/L)
Digoxin
use and Hypokalemia predisposes to
Arrhythmia
Renal
Metabolic Alkalosis
Polyuria
, Polydipsia
Decreased GFR
Glucose Intolerance
Labs
Serum Potassium
<3.5 mEq/L
Serum Magnesium
Confirm no
Hypomagnesemia
(Hypokalemia cause)
Complete Blood Count
Confirm no severe
Leukocytosis
(pseudohypokalemia)
24 hour
Urine Potassium
and
Urine Sodium
Most accurate evaluation of
Urine Potassium
excretion
However,
Urine Potassium
-to-
Creatinine
ratio is typically obtained instead
Sample should have total
Urine Sodium
> 100 meq
Urine Potassium
<20-30 meq/day
See
Extrarenal Potassium Loss
Urine Potassium
>20-30 meq/day
See
Renal Potassium Loss
Urine Potassium
-to-
Creatinine
ratio
Ratio <=1.5 mEq/mmol:
Hypokalemia due to Extrarenal Potassium Loss
Manage underlying losses
Ratio >1.5 mEq/mmol:
Hypokalemia due to Renal Potassium Loss
Elevated
Blood Pressure
or hypervolemia (mineralcorticoid excess)
Hyperaldosteronism
Renal Artery Stenosis
Cushing Syndrome
Congenital Adrenal Hyperplasia
Metabolic Acidosis
Type I and II
Renal Tubular Acidosis
Metabolic Alkalosis
Diuretic
s
Renal Tubular transport disorders (e.g. Bartter Syndrome)
Diagnostics
Electrocardiogram
Early changes
T Wave
s decreased amplitude to flattened
Later changes
Prominent
U Wave
s
ST depression (esp. mid-precordial leads, V2, V3)
ST may appear to sag downwards from a normal
J Point
May give rise to a biphasic appearing
T Wave
May end in an upright
U Wave
T Wave Inversion
Biphasic
T Wave
(mid-precordial leads, V1-V3)
Mattu (2017) Crit Dec Emerg Med 31(3): 11
PR prolongation (first degree
AV Block
)
QTc Prolongation
Arrhythmia
s associated with Hypokalemia
Sinus Bradycardia
Ventricular Tachycardia
or
Ventricular Fibrillation
Torsade de pointes
References
Mattu (2021) Crit Dec Emerg Med 35(3):14
Management
Gene
ral
Potassium Replacement
Goal
Serum Potassium
>3.5 mEq/L (>4.0 in CAD, CHF)
Expect 0.1 mEq increase in
Serum Potassium
for every 10 mEq
Potassium
administered
Total body
Potassium
deficit
Serum Potassium
: <3.5 mEq/L = 100 meq total
Potassium
deficit
Serum Potassium
: 3.2 mEq/L = 200 meq total
Potassium
deficit
Serum Potassium
: 2.9 mEq/L= 300 meq total
Potassium
deficit
Serum Potassium
: 2.6 mEq/L = 400 meq total
Potassium
deficit
Avoid rebound
Hyperkalemia
(over-shooting replacement)
Hyperkalemia
with replacement is unlikely if normal
Renal Function
, adequate fluid intake
Dietary Potassium
(
Potassium
phosphate) is less efficient replacement than
Potassium
chloride
Most Hypokalemia is associated with concurrent chloride depletion
However
Potassium
chloride compliance is poor (
Dyspepsia
,
Dietary Potassium
tastes better)
Half of
Potassium Replacement
is typically excreted by the
Kidney
s
Aside from
Renal Failure
and
Dehydration
, at least half of
Potassium Replacement
(esp. oral) is excreted
Approximate oral
Potassium Replacement
Start intravenous
Potassium Replacement
if
Serum Potassium
<2.5 mEq
Serum Potassium
2.5 mEq to 3.0 mEq/L (total body deficit 200-300 meq)
Start with KCl 20 meq orally every 2 hours for 4 doses and consider recheck level at 4 hours
Typically continue
Potassium Replacement
at 20 meq twice daily for 4-5 days
Serum Potassium
: 3.0 to 3.5 mEq/L(total body deficit 100-200 meq)
Give KCl 20 mEq orally every 2 hours for 2 doses OR KCl 40 mEq once
Typically continue
Potassium Replacement
at 20 meq twice daily for 2-3 days
Other
Potassium Replacement
See
Potassium Replacement
Intravenous
Potassium Replacement
See emergent replacement indications below
Oral replacement other than with
Potassium
chloride (which is typically preferred)
Potassium
bicarbonate (or oral preparations with citrate or gluconate, or IV
Potassium
acetate)
Consider in
Metabolic Acidosis
with Hypokalemia
Potassium
phosphate (IV)
Indicated in Hypokalemia with
Hypophosphatemia
(e.g.
Refeeding Syndrome
, RTA 2,
Fanconi Syndrome
)
Magnesium Replacement
(empirically or based on lab demonstrated
Hypomagnesemia
)
Especially consider empiric
Magnesium Replacement
in refractory Hypokalemia
Take oral
Magnesium Supplement
400-500 mg tabs 1-2 daily along with
Potassium
supplement
Emergent replacement (IV
Potassium
chloride Replacement) indicated for serious findings or risks
EKG changes (esp.
QTc Prolongation
, see above)
Severe Hypokalemia (
Serum Potassium
<2.5 mEq/L)
Rapid onset Hypokalemia
Serious comorbidity (heart disease,
Cirrhosis
)
Consider pseudohypokalemia
Consider re-drawing lab for confirmation if delayed analysis
Confirm no severe
Leukocytosis
(WBC >75,000/mm3)
Consider
Transcellular Potassium Shift
See
Transcellular Potassium Shift
Hypokalemia from transcellular shift is typically transient
Management
Hospital Replacement Criteria
Hypokalemia with
Serum Potassium
<3.0 mEq/L AND
QTc Prolongation
>500 ms
Severe Hypokalemia with
Serum Potassium
<2.5 mEq/L
Prevention
Modify
Antihypertensive
regimen
Decrease or eliminate
Diuretic
s
Add
ACE Inhibitor
or
Angiotensin Receptor Blocker
(ARB)
Dietary Changes
Follow Low salt diet
Increase
Dietary Potassium
(may be insufficient to replace
Potassium
chloride losses)
Potassium Supplementation
Potassium
chloride 50 to 75 meq per day increases
Serum Potassium
0.14 mEq/L
References
Orman and Slovis in Herbert (2018) EM:Rap 18(8): 4-5
Kim (2023) Am Fam Physician 107(1): 59-70 [PubMed]
Viera (2015) Am Fam Physician 92(6): 487-95 [PubMed]
Type your search phrase here